Lilly Endowment Amends Eli Lilly Stake, Passive Ownership Confirmed
Ticker: LLY · Form: SC 13G/A · Filed: Jan 26, 2024 · CIK: 59478
| Field | Detail |
|---|---|
| Company | Eli Lilly & Co (LLY) |
| Form Type | SC 13G/A |
| Filed Date | Jan 26, 2024 |
| Risk Level | low |
| Pages | 3 |
| Reading Time | 4 min |
| Sentiment | neutral |
Complexity: simple
Sentiment: neutral
Topics: institutional-ownership, passive-investing, amendment
TL;DR
**Lilly Endowment still holds Eli Lilly stock, no activist moves planned.**
AI Summary
Lilly Endowment Inc. filed an amended SC 13G/A on January 26, 2024, reporting its ownership of Eli Lilly and Company common stock as of December 31, 2023. This filing, Amendment No. 39, indicates a passive ownership stake, meaning the Endowment does not intend to influence or control Eli Lilly's management. For investors, this filing confirms a significant, long-term institutional holder maintains its position, which can be seen as a vote of confidence in Eli Lilly's stability and future prospects.
Why It Matters
This filing confirms that a major, long-standing shareholder, Lilly Endowment Inc., continues to hold a significant, passive stake in Eli Lilly and Company, signaling stability and a lack of immediate activist pressure.
Risk Assessment
Risk Level: low — The filing indicates a passive ownership stake, suggesting no immediate risk of disruptive shareholder activism or significant changes in company control.
Analyst Insight
Investors should note the continued passive ownership by Lilly Endowment Inc., which suggests long-term stability in the shareholder base and no immediate signs of activist intervention, allowing focus on Eli Lilly's operational performance.
Key Players & Entities
- Lilly Endowment Inc. (company) — the reporting person and a significant shareholder of Eli Lilly and Company
- Eli Lilly and Company (company) — the issuer whose common stock is being reported
- 03 Life Sciences (company) — an organization name associated with the subject company, Eli Lilly & Co.
FAQ
What type of filing is this document?
This document is an SC 13G/A, which is an amendment (Amendment No. 39) to a Schedule 13G, filed under the Securities Exchange Act of 1934.
Who is the 'Reporting Person' in this filing?
The Reporting Person is LILLY ENDOWMENT INC., as stated in Item 1 of the cover page.
What is the 'Subject Company' or 'Issuer' of the securities being reported?
The Subject Company or Issuer is Eli Lilly and Company, whose common stock is being reported, as indicated in the filing's title and body.
What is the CUSIP Number for the securities mentioned in this filing?
The CUSIP Number for the Common Stock, Without Par Value of Eli Lilly and Company is 532457-10-8, as listed on the cover page.
What was the 'Date of Event Which Requires Filing of this Statement'?
The Date of Event Which Requires Filing of this Statement was December 31, 2023, as specified on the cover page of the filing.
Filing Stats: 1,023 words · 4 min read · ~3 pages · Grade level 9.4 · Accepted 2024-01-26 16:25:45
Filing Documents
- lilly240086_sc13ga.htm (SC 13G/A) — 47KB
- 0000897101-24-000026.txt ( ) — 48KB
If this statement is filed pursuant to §§ 240.13d1(b) or 240.13d2(b) or (c), check whether the person
Item 3. If this statement is filed pursuant to §§ 240.13d1(b) or 240.13d2(b) or (c), check whether the person filing is a: (a) o Broker or dealer registered under section 15 of the Act. (b) o Bank as defined in section 3(a)(6) of the Act. (c) o Insurance company as defined in section 3(a)(19) of the Act. (d) o Investment company registered under section 8 of the Investment Company Act of 1940. (e) o An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E). (f) o An employee benefit plan or endowment fund in accordance with § 240.13d1(b)(1)(ii)(F). (g) o A parent holding company or control person in accordance with § 240.13d1(b)(1)(ii)(G). (h) o A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act. (i) o A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940. (k) o A group, in accordance with§ 240. I 3d-l(b)(l )(ii)(K). If filing as a non-U.S. institution in accordance with§ 240.13d-l(b)(I)(ii)(J), please specify the type of institution. 3 of 5
Ownership
Item 4. Ownership (a) Amount Beneficially Owned 99,768,810 (b) Percent of Class 10.51% (c) Number of shares as to which such person has: (i) Sole power to vote or to direct the vote 99,768,810 (ii) Shared power to vote or to direct the vote 0 (iii) Sole power to dispose or to direct the disposition of 99,768,810 (iv) Shared power to dispose or to direct the disposition of 0
Ownership of Five Percent or Less of a Class
Item 5. Ownership of Five Percent or Less of a Class If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following o . Not Applicable.
Ownership of More than Five Percent on Behalf of Another Person
Item 6. Ownership of More than Five Percent on Behalf of Another Person. Not Applicable Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company or Control Person. Not Applicable
Identification and Classification of Members of the Group
Item 8. Identification and Classification of Members of the Group Not Applicable
Notice of Dissolution of Group
Item 9. Notice of Dissolution of Group Not Applicable
Certification
Item 10. Certification Not Applicable 4 of 5 SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Date: January 19, 2024 Lilly Endowment Inc. By: /s/ Diane M. Stenson Name: Diane M. Stenson Title: Vice President & Treasurer Footnotes:
: This information is provided as of December 31, 2023
Item 4: This information is provided as of December 31, 2023.
(a): None of such shares are deemed to be beneficially owned by
Item 4(a): None of such shares are deemed to be beneficially owned by reason of the possession of Lilly Endowment Inc. of a right to acquire such shares.
(b): The percent of class represented is based on 949,307,237 shares
Item 4(b): The percent of class represented is based on 949,307,237 shares of common stock outstanding as of October 30, 2023 as reported on the Issuer's Form 10Q for the period ended September 30, 2023. 5 of 5